HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma.

AbstractBACKGROUND AND PURPOSE:
The role of adjuvant radiotherapy for central neurocytomas (CNs) is not clear. Therefore, we aimed to examine the clinical outcomes of treating histologically confirmed CNs with adjuvant RT after surgical resection.
MATERIAL AND METHODS:
Sixty-three CN patients were retrospectively evaluated: 24 patients underwent gross total resection (GTR); 28, subtotal resection (STR); 9, partial resection (PR), and 2, biopsy (Bx). They underwent adjuvant RT after surgery (median dose, 54 Gy).
RESULTS:
The median follow-up was 69 months (15-129 months). The 5-year overall survival (OS) and 5-year progression-free survival (PFS) were 94.4% and 95% after GTR + RT, 96.4% and 100% after STR + RT, and 100% and 90.9% after PR + RT. Only three patients had tumor recurrence: at the primary site at 30 and 24 months in two GTR + PR patients, and dissemination to the spinal cord at 75 months in one STR + RT patient. Thirty-eight (63.3%) patients experienced late neurotoxicity (28, grade 1; 7, grade 2; 3, grade 3). Short-term memory impairment was the most common toxicity.
CONCLUSIONS:
RT after incomplete resection (IR) led to OS and PFS comparable to those for GTR. Considering the excellent outcomes and limited late toxicity, adjuvant RT maybe a good option for CN patients who undergo IR.
AuthorsYi-Dong Chen, Wen-Bin Li, Jin Feng, Xiao-Guang Qiu
JournalRadiation oncology (London, England) (Radiat Oncol) Vol. 9 Pg. 242 (Nov 06 2014) ISSN: 1748-717X [Electronic] England
PMID25373333 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Brain Neoplasms (mortality, radiotherapy, surgery)
  • Child
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Neurocytoma (mortality, radiotherapy, surgery)
  • Radiation Injuries (epidemiology)
  • Radiotherapy Dosage
  • Radiotherapy, Adjuvant (adverse effects)
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: